Biotech firm Humacyte is pushing its cutting-edge lab-grown blood vessels for uses far beyond what regulators have allowed.
«One of those presentations focused on off-label use of the vessels in patients’ torsos, which, according to data omitted from a prominent medical article on the product, were unsuccessful in four out of five procedures. In two of those cases, the patient died.»
#biotech #fda #OffLabel #ConflictOfInterest #BloodVessel
https://www.levernews.com/regulatory-ruptures-for-a-lab-grown-blood-vessel/



